FOLLOW US FOR MORE
The question for life sciences leaders is no longer if they should adopt Generative AI, but how to invest strategically to unlock maximum impact. With dozens of critical applications - from accelerating clinical trials to optimizing regulatory submissions - identifying the use cases that offer the highest value with the least risk is the primary challenge.
This report cuts through the hype - Gartner plots 20 prominent GenAI use cases against their business value and feasibility to provide a strategic roadmap for your investment decisions.
This Gartner® report, as per our analysis, equips life sciences enterprises with the clarity needed to build a winning GenAI roadmap.
Rapid Expansion Underway
59%
of life sciences organizations have expanded GenAI into new functional or business domains in the past 1 year.
The ‘Likely Wins’
13
high-value, high-feasibility use cases that win in most circumstances.
Where The Leaders Focus
3
key areas leaders are currently deploying GenAI in:
commercialization (33%), clinical development (33%), and drug discovery (30%)
AI tools often live at the edges of the workflow of critical workflows, making them hard to discover and adopt. Whatfix brings these assistants directly into the flow of work proactively surfacing them contextually at the exact moment they add value, whether it’s in clinical trials, drug discovery, or commercialization. With in-app nudges, proactive guidance, and adoption analytics, Whatfix ensures scientists, trial managers, and sales teams not only use AI but rely on it with confidence - unlocking measurable ROI from digital investments.
Disclaimer - Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose. This graphic was published by Gartner, Inc. as part of a larger research document and should be evaluated in the context of the entire document. The Gartner document is available upon request from Whatfix.
GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved.
Generative AI Use-Case Assessment for Life Sciences Reuben Harwood, Jeff Smith, Animesh Gandhi, Michael Shanler, Evun Wyer, 12 August 2025
Copyright © 2025 WHATFIX. All rights reserved.
